Neurologists at a memory clinic in China have diagnosed a 19-year-old with what they believe to be Alzheimer's disease, making him the youngest person in the world to be diagnosed with the condition.

The male teenager began experiencing memory problems around age 17, and the cognitive decline only worsened over the years.

No one wants to get that call…

You know, the one where your doctor tells you, “It’s dementia… and it’s not going to get any better.”

That’s because this life-changing disease can slowly strip away your health and independence.

Fortunately, new research shows there’s a “leisurely” way to end dementia before it starts. And it couldn’t be easier or more enjoyable.

When children don’t pay attention, act impulsively, or are hyperactive - a doctor may diagnose ADHD and prescribe medication to help them have better focus, control their impulses and feel more calm.

There are a number of drugs available to help both children and adults with ADHD, but one in particular is catching the eye of researchers for its ability to also help people with Alzheimer’s disease.

An experimental drug (lecanemab) for Alzheimer's disease from Eisai and Biogen slowed cognitive decline in a closely watched trial, however, it may carry a risk of dangerous side-effects for certain patients, according to new data presented last week.

It's known that keeping your brain active through brain games can stave off age-related memory loss. But there’s a different kind of “brain activity” you’ll want to avoid for better longevity.

Too much electrical activity in your brain is linked to numerous disorders ranging from autism and epilepsy to Alzheimer’s disease.

Taking a daily multivitamin and mineral tablet may slow the gradual cognitive decline that happens naturally as we get older.

At the end of a three-year trial, people who had taken a commercially available multivitamin-mineral supplement had a cognitive age that was 1.8 years younger than those who took a placebo.

For more than 15 years, the global scientific community researching Alzheimer’s Disease has focused its attention—and hundreds of millions of research dollars—on the theory that the disease is primarily caused by the build-up of plaque, called amyloid beta, in the brain. But what if that theory is based on flawed data?

A six-month investigation by Charles Piller, an award-winning reporter for Science magazine, finds that key research published in 2006 may have included fabricated data.

You probably havn't heard of farnesol. But you've probably smelled or tasted it, because it's a compound found in essential oils and is used in candles and incense, perfumes, air fresheners, soaps, and food flavors.

Farnesol also has many medicinal uses and thanks to a new discovery by scientists at Johns Hopkins University, we now know that farnesol may have the potential to prevent or treat Parkinson's disease.

There’s another new test on the horizon that claims to help diagnose cognitive decline in its earliest stages, before severe memory loss takes hold. This minimally invasive and inexpensive blood test was developed by a pioneering team of researchers in Germany.

Unlike other diagnostic tests, it’s not specific to uncovering any single neurodegenerative disease but instead measures the brain’s overall cognitive health.